Unlocking the promise of RAS inhibition in pancreatic cancer

Nat Rev Gastroenterol Hepatol. 2024 Aug;21(8):535-536. doi: 10.1038/s41575-024-00951-y.

Authors

Saurav D Haldar¹, Nilofer S Azad²

Affiliations

¹ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].

PMID: 38877211
DOI: 10.1038/s41575-024-00951-y

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use
Humans
Pancreatic Neoplasms* / drug therapy
ras Proteins / genetics
ras Proteins / metabolism

Substances

ras Proteins
Antineoplastic Agents